Novel sequential treatment with palbociclib enhances the effect of cisplatin in RB-proficient triple-negative breast cancerYajing Huang(Tongji Hospital), Xingrui Li(Huazhong University of Science and Technology)Cancer Cell InternationalOctober 12, 202010.1186/s12935-020-01597-xCited by 21SaveCiteExport RISWatch citationsRelated Papers<p>Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway</p>|OncoTargets and Therapy|2019|75HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia|JAMA Oncology|2017|48A Novel Sequential Treatment of Palbociclib Enhances the Effect of Cisplatin in RB-Proficient Triple-Negative Breast Cancer|Research Square|2020|0